Anissa A. Widjaja

Inhibition of IL-11 signalling extends mammalian healthspan and lifespan

A high-resolution map of human RNA translation

Thyroid Hormone Decreases Hepatic Steatosis, Inflammation, and Fibrosis in a Dietary Mouse Model of Nonalcoholic Steatohepatitis

Targeting endogenous kidney regeneration using anti-IL11 therapy in acute and chronic models of kidney disease

IL11 Stimulates IL33 Expression and Proinflammatory Fibroblast Activation across Tissues

IL11 stimulates ERK/P90RSK to inhibit LKB1/AMPK and activate mTOR initiating a mesenchymal program in stromal, epithelial, and cancer cells

Interleukin-11 drives human and mouse alcohol-related liver disease

Hepatocyte-specific IL11 cis-signaling drives lipotoxicity and underlies the transition from NAFLD to NASH

Redefining IL11 as a regeneration-limiting hepatotoxin and therapeutic target in acetaminophen-induced liver injury

IL11 is elevated in systemic sclerosis and IL11-dependent ERK signalling underlies TGFβ-mediated activation of dermal fibroblasts

Molecular Dissection of Pro-Fibrotic IL11 Signaling in Cardiac and Pulmonary Fibroblasts

Fibroblast‐specific IL11 signaling drives chronic inflammation in murine fibrotic lung disease

Transgenic interleukin 11 expression causes cross-tissue fibro-inflammation and an inflammatory bowel phenotype in mice

Interleukin-11 is important for vascular smooth muscle phenotypic switching and aortic inflammation, fibrosis and remodeling in mouse models

Different roles of interleukin 6 and interleukin 11 in the liver: implications for therapy

The Translational Landscape of the Human Heart

Interleukin-11 is a therapeutic target in idiopathic pulmonary fibrosis

Inhibiting Interleukin 11 Signaling Reduces Hepatocyte Death and Liver Fibrosis, Inflammation, and Steatosis in Mouse Models of Nonalcoholic Steatohepatitis

IL-11 is a crucial determinant of cardiovascular fibrosis